|
|
||||||||
|
|
|||||||||
|
|
Oncology-Basic Science: Therapy, Metrics & InterventionTherapy, Metrics & Intervention Posters |
1 Nuclear Medicine, S. Orsola-Malpighi Hospital, Bologna, Italy; 2 Experimental Surgery, Isituti Ortopedici Rizzoli, Bologna, Italy; 3 Pathology, S. Orsola-Malpighi Hospital, Bologna, Italy; 4 Nuclear Medicine, S. Maria della Misericordia Hospital, Rovigo, Italy
1416
Objectives: To monitor human lung non-small cells carcinoma xenograft growth in nu/nu mice by 18F-FDG Small Animal PET.
Methods: Human cell line HCC15 (lung squamous cells carcinoma) was subcutaneously inoculated (107cells/mouse in 100ul PBS) in seven 6weeks-old nu/nu mice at right flank level. Tumour growth was serially monitored by 18F-FDG Small Animal PET (18F-FDG i.v. injected dose: 20MBq in <0,15ml; uptake time=60minutes, 15minutes static acquisition of 1 bed position) at 7, 14, 21 and 35 days after cells injection. PET scans were performed under gas (Sevofluorane 5%, Oxygen 1L/min) anaesthesia. FDG-PET images were reconstructed iteratively (OSEM 2D) and read in three planes. PET was considered positive if any area of increased non-physiologic FDG uptake was observed. Semi-quantitative analysis was performed using the TBR (max counts in target ROI/mean counts in the background). Tumour volume was measured by caliper and calculated as major diameter x minor diameter2/2. Tumour burden was calculated for each scan as mean TBR x mean tumour volume.
Results: PET was positive at 7 days in 2 animals and at 14 days in 4. TBR showed a mild decrease over time while tumour volume rapidly increased (figure 1). The tumour burden progressively increased (figure 2).
Conclusions: Small animal PET detected xenograft tumours 7 days after implantation, thus earlier then macroscopic evaluation. The trend of the TBR and tumour volume suggests to perform additional PET scans before 7 days and between 7 and 14 days in order to detect the smallest tumour lesion.
| ||||||||||||||||||||||||||||||||||||||